Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

P&G financials

This article was originally published in The Tan Sheet

Executive Summary

Health Care sales advanced 18% to $1.4 bil. in third quarter (ended March 31), fueled by continued strength in oral care business, consumer products firm announces in April 28 1financial release. Price adjustments aimed at positioning Crest Whitestrips more competitively against Colgate Simply White offset a 3% positive currency impact during the period. P&G delayed launch of companion Whitestrips product, Crest Night Effects, from March until end of April because production could not meet retailer demand, firm says. Health Care earnings increased 19% to $147 mil. in Q3...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS095433

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel